Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-Family Member Expression

Thumbnail
View/ Open

Show full item record
Author
McCubrey, James A.
URI
http://hdl.handle.net/10342/9628
Subject
 drug transporters; MEK1; cancer stem cells 
Date
2017-12-06
Citation:
APA:
McCubrey, James A.. (December 2017). Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-Family Member Expression. , (), - . Retrieved from http://hdl.handle.net/10342/9628

Display/Hide MLA, Chicago and APA citation formats.

MLA:
McCubrey, James A.. "Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-Family Member Expression". . . (), December 2017. January 31, 2023. http://hdl.handle.net/10342/9628.
Chicago:
McCubrey, James A., "Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-Family Member Expression," , no. (December 2017), http://hdl.handle.net/10342/9628 (accessed January 31, 2023).
AMA:
McCubrey, James A.. Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-Family Member Expression. . December 2017; (): . http://hdl.handle.net/10342/9628. Accessed January 31, 2023.
Collections